News FDA clears Moderna's mRNA-based seasonal flu shot After a series of regulatory twists and turns, the FDA has approved Moderna's mRNA-based influenza vaccine mFlusiva.
News Moderna starts first trial of its Bundibugyo Ebola vaccine Moderna has started first-in-human testing of its mRNA vaccine against Bundibugyo Ebola virus, as the outbreak in DRC gathers pace.
News Lawmakers seek answers from RFK on Gardasil shot settlement Four Democratic senators are investigating whether the family of HHS Secretary RFK Jr is profiting from what they assert are "bogus" vaccine lawsuits.
News UK experts call for meningitis shots for all 15-year-olds All 15-year-olds in the UK should be offered the meningitis B vaccine following the fatal outbreaks earlier this year, says the JCVI.
News First trial of Bundibugyo Ebola vaccine starts in UK Oxford University has launched what it says is the world's first phase I trial of a vaccine specifically designed to protect against Bundibugyo Ebola.
News Moderna's mResvia gets shot in the arm from EU contract A new EU procurement contract could give Moderna's RSV shot mResvia, which has struggled to gain traction in the market, a welcome boost.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
